<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1987-08-13" modified="2020-10-07" version="232">
<accession>P05231</accession>
<accession>Q9UCU2</accession>
<accession>Q9UCU3</accession>
<accession>Q9UCU4</accession>
<name>IL6_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="25">Interleukin-6</fullName>
<shortName>IL-6</shortName>
</recommendedName>
<alternativeName>
<fullName>B-cell stimulatory factor 2</fullName>
<shortName>BSF-2</shortName>
</alternativeName>
<alternativeName>
<fullName>CTL differentiation factor</fullName>
<shortName>CDF</shortName>
</alternativeName>
<alternativeName>
<fullName>Hybridoma growth factor</fullName>
</alternativeName>
<alternativeName>
<fullName>Interferon beta-2</fullName>
<shortName>IFN-beta-2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="27">IL6</name>
<name type="synonym">IFNB2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1986" name="Nature" volume="324" first="73" last="76">
<title>Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.</title>
<authorList>
<person name="Hirano T."/>
<person name="Yasukawa K."/>
<person name="Harada H."/>
<person name="Taga T."/>
<person name="Watanabe Y."/>
<person name="Matsuda T."/>
<person name="Kashiwamura S."/>
<person name="Nakajima K."/>
<person name="Koyama K."/>
<person name="Iwamatsu A."/>
<person name="Tsunasawa S."/>
<person name="Sakiyama F."/>
<person name="Matsui H."/>
<person name="Takahara Y."/>
<person name="Taniguchi T."/>
<person name="Kishimoto T."/>
</authorList>
<dbReference type="PubMed" id="3491322"/>
<dbReference type="DOI" id="10.1038/324073a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1987" name="EMBO J." volume="6" first="2939" last="2945">
<title>Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene.</title>
<authorList>
<person name="Yasukawa K."/>
<person name="Hirano T."/>
<person name="Watanabe Y."/>
<person name="Muratani K."/>
<person name="Matsuda T."/>
<person name="Nakai S."/>
<person name="Kishimoto T."/>
</authorList>
<dbReference type="PubMed" id="3500852"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1987.tb02598.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1986" name="Proc. Natl. Acad. Sci. U.S.A." volume="83" first="8957" last="8961">
<title>Anti-beta-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the beta 2 interferon involved.</title>
<authorList>
<person name="May L.T."/>
<person name="Helfgott D.C."/>
<person name="Sehgal P.B."/>
</authorList>
<dbReference type="PubMed" id="3538015"/>
<dbReference type="DOI" id="10.1073/pnas.83.23.8957"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1986" name="EMBO J." volume="5" first="2529" last="2537">
<title>Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines.</title>
<authorList>
<person name="Zilberstein A."/>
<person name="Ruggieri R."/>
<person name="Korn J.H."/>
<person name="Revel M."/>
</authorList>
<dbReference type="PubMed" id="3023045"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1986.tb04531.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1987" name="J. Immunol." volume="139" first="4116" last="4121">
<title>Molecular cloning and expression of hybridoma growth factor in Escherichia coli.</title>
<authorList>
<person name="Brakenhoff J.P.J."/>
<person name="de Groot E.R."/>
<person name="Evers R.F."/>
<person name="Pannekoek H."/>
<person name="Aarden L.A."/>
</authorList>
<dbReference type="PubMed" id="3320204"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1989" name="Biochem. Biophys. Res. Commun." volume="163" first="1056" last="1062">
<title>Deletion of 3' untranslated region of human BSF-2 mRNA causes stabilization of the mRNA and high-level expression in mouse NIH3T3 cells.</title>
<authorList>
<person name="Tonouchi N."/>
<person name="Miwa K."/>
<person name="Karasuyama H."/>
<person name="Matsui H."/>
</authorList>
<dbReference type="PubMed" id="2789513"/>
<dbReference type="DOI" id="10.1016/0006-291x(89)92328-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1986" name="Eur. J. Biochem." volume="159" first="625" last="632">
<title>Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts.</title>
<authorList>
<person name="Haegeman G."/>
<person name="Content J."/>
<person name="Volckaert G."/>
<person name="Derynck R."/>
<person name="Tavernier J."/>
<person name="Fiers W."/>
</authorList>
<dbReference type="PubMed" id="3758081"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1986.tb09931.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]</scope>
<source>
<tissue>Fibroblast</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1988" name="Behring Inst. Mitt." volume="83" first="40" last="47">
<title>Interleukin 6: identification as a hematopoietic colony-stimulating factor.</title>
<authorList>
<person name="Wong G."/>
<person name="Witek-Giannotti J."/>
<person name="Hewick R."/>
<person name="Clark S."/>
<person name="Ogawa M."/>
</authorList>
<dbReference type="PubMed" id="3266463"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1992" name="Zhonghua Zhong Liu Za Zhi" volume="14" first="340" last="344">
<title>Stable and efficient expression of human interleukin-6 cDNA in mammalian cells after gene transfer.</title>
<authorList>
<person name="Chen Q.Y."/>
</authorList>
<dbReference type="PubMed" id="1291290"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="10">
<citation type="submission" date="2001-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS SER-32 AND VAL-162</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="1988" name="J. Immunol." volume="140" first="1534" last="1541">
<title>Separation and comparison of two monokines with lymphocyte-activating factor activity: IL-1 beta and hybridoma growth factor (HGF). Identification of leukocyte-derived HGF as IL-6.</title>
<authorList>
<person name="van Damme J."/>
<person name="van Beeumen J."/>
<person name="Decock B."/>
<person name="van Snick J."/>
<person name="de Ley M."/>
<person name="Billiau A."/>
</authorList>
<dbReference type="PubMed" id="3279116"/>
</citation>
<scope>PROTEIN SEQUENCE OF 30-63</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1989" name="J. Mol. Cell. Immunol." volume="4" first="203" last="211">
<title>Interleukin 6 is the principal cytolytic T lymphocyte differentiation factor for thymocytes in human leukocyte conditioned medium.</title>
<authorList>
<person name="Ming J.E."/>
<person name="Cernetti C."/>
<person name="Steinman R.M."/>
<person name="Granelli-Piperno A."/>
</authorList>
<dbReference type="PubMed" id="2610854"/>
</citation>
<scope>PROTEIN SEQUENCE OF 30-50</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1991" name="Cytokine" volume="3" first="204" last="211">
<title>Marked cell-type-specific differences in glycosylation of human interleukin-6.</title>
<authorList>
<person name="May L.T."/>
<person name="Shaw J.E."/>
<person name="Khanna A.K."/>
<person name="Zabriskie J.B."/>
<person name="Sehgal P.B."/>
</authorList>
<dbReference type="PubMed" id="1883960"/>
<dbReference type="DOI" id="10.1016/1043-4666(91)90018-9"/>
</citation>
<scope>PROTEIN SEQUENCE OF 30-40</scope>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1995" name="Eur. J. Biochem." volume="227" first="573" last="581">
<title>Structure, stability and biological properties of a N-terminally truncated form of recombinant human interleukin-6 containing a single disulfide bond.</title>
<authorList>
<person name="Breton J."/>
<person name="la Fiura A."/>
<person name="Bertolero F."/>
<person name="Orsini G."/>
<person name="Valsasina B."/>
<person name="Ziliotto R."/>
<person name="de Filippis V."/>
<person name="Polverino de Laureto P."/>
<person name="Fontana A."/>
</authorList>
<dbReference type="PubMed" id="7851440"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1995.tb20427.x"/>
</citation>
<scope>PROTEIN SEQUENCE OF 50-212</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1989" name="Arch. Biochem. Biophys." volume="272" first="144" last="151">
<title>Disulfide structures of human interleukin-6 are similar to those of human granulocyte colony stimulating factor.</title>
<authorList>
<person name="Clogston C.L."/>
<person name="Boone T.C."/>
<person name="Crandall B.C."/>
<person name="Mendiaz E.A."/>
<person name="Lu H.S."/>
</authorList>
<dbReference type="PubMed" id="2472117"/>
<dbReference type="DOI" id="10.1016/0003-9861(89)90205-1"/>
</citation>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1991" name="FEBS Lett." volume="282" first="265" last="267">
<title>Evidence for the importance of a positive charge and an alpha-helical structure of the C-terminus for biological activity of human IL-6.</title>
<authorList>
<person name="Luetticken C."/>
<person name="Kruettgen A."/>
<person name="Moeller C."/>
<person name="Heinrich P.C."/>
<person name="Rose-John S."/>
</authorList>
<dbReference type="PubMed" id="2037043"/>
<dbReference type="DOI" id="10.1016/0014-5793(91)80491-k"/>
</citation>
<scope>MUTAGENESIS</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2000" name="J. Physiol. (Lond.)" volume="529" first="237" last="242">
<title>Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6.</title>
<authorList>
<person name="Steensberg A."/>
<person name="van Hall G."/>
<person name="Osada T."/>
<person name="Sacchetti M."/>
<person name="Saltin B."/>
<person name="Klarlund Pedersen B."/>
</authorList>
<dbReference type="PubMed" id="11080265"/>
<dbReference type="DOI" id="10.1111/j.1469-7793.2000.00237.x"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION BY EXERCISE</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2003" name="Arthritis Rheum." volume="48" first="1521" last="1529">
<title>Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.</title>
<authorList>
<person name="Nakahara H."/>
<person name="Song J."/>
<person name="Sugimoto M."/>
<person name="Hagihara K."/>
<person name="Kishimoto T."/>
<person name="Yoshizaki K."/>
<person name="Nishimoto N."/>
</authorList>
<dbReference type="PubMed" id="12794819"/>
<dbReference type="DOI" id="10.1002/art.11143"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="J. Clin. Invest." volume="113" first="1271" last="1276">
<title>IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.</title>
<authorList>
<person name="Nemeth E."/>
<person name="Rivera S."/>
<person name="Gabayan V."/>
<person name="Keller C."/>
<person name="Taudorf S."/>
<person name="Pedersen B.K."/>
<person name="Ganz T."/>
</authorList>
<dbReference type="PubMed" id="15124018"/>
<dbReference type="DOI" id="10.1172/jci200420945"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Arthritis Rheum." volume="54" first="3551" last="3563">
<title>Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system.</title>
<authorList>
<person name="De Benedetti F."/>
<person name="Rucci N."/>
<person name="Del Fattore A."/>
<person name="Peruzzi B."/>
<person name="Paro R."/>
<person name="Longo M."/>
<person name="Vivarelli M."/>
<person name="Muratori F."/>
<person name="Berni S."/>
<person name="Ballanti P."/>
<person name="Ferrari S."/>
<person name="Teti A."/>
</authorList>
<dbReference type="PubMed" id="17075861"/>
<dbReference type="DOI" id="10.1002/art.22175"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="Am. J. Physiol." volume="299" first="E832" last="E840">
<title>IL-6 selectively stimulates fat metabolism in human skeletal muscle.</title>
<authorList>
<person name="Wolsk E."/>
<person name="Mygind H."/>
<person name="Groendahl T.S."/>
<person name="Pedersen B.K."/>
<person name="van Hall G."/>
</authorList>
<dbReference type="PubMed" id="20823453"/>
<dbReference type="DOI" id="10.1152/ajpendo.00328.2010"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="Nat. Med." volume="17" first="1481" last="1489">
<title>Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.</title>
<authorList>
<person name="Ellingsgaard H."/>
<person name="Hauselmann I."/>
<person name="Schuler B."/>
<person name="Habib A.M."/>
<person name="Baggio L.L."/>
<person name="Meier D.T."/>
<person name="Eppler E."/>
<person name="Bouzakri K."/>
<person name="Wueest S."/>
<person name="Muller Y.D."/>
<person name="Hansen A.M."/>
<person name="Reinecke M."/>
<person name="Konrad D."/>
<person name="Gassmann M."/>
<person name="Reimann F."/>
<person name="Halban P.A."/>
<person name="Gromada J."/>
<person name="Drucker D.J."/>
<person name="Gribble F.M."/>
<person name="Ehses J.A."/>
<person name="Donath M.Y."/>
</authorList>
<dbReference type="PubMed" id="22037645"/>
<dbReference type="DOI" id="10.1038/nm.2513"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2015" name="Cell" volume="161" first="1619" last="1632">
<title>A single kinase generates the majority of the secreted phosphoproteome.</title>
<authorList>
<person name="Tagliabracci V.S."/>
<person name="Wiley S.E."/>
<person name="Guo X."/>
<person name="Kinch L.N."/>
<person name="Durrant E."/>
<person name="Wen J."/>
<person name="Xiao J."/>
<person name="Cui J."/>
<person name="Nguyen K.B."/>
<person name="Engel J.L."/>
<person name="Coon J.J."/>
<person name="Grishin N."/>
<person name="Pinna L.A."/>
<person name="Pagliarini D.J."/>
<person name="Dixon J.E."/>
</authorList>
<dbReference type="PubMed" id="26091039"/>
<dbReference type="DOI" id="10.1016/j.cell.2015.05.028"/>
</citation>
<scope>PHOSPHORYLATION AT SER-81</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2015" name="Nature" volume="519" first="57" last="62">
<title>A gp130-Src-YAP module links inflammation to epithelial regeneration.</title>
<authorList>
<person name="Taniguchi K."/>
<person name="Wu L.W."/>
<person name="Grivennikov S.I."/>
<person name="de Jong P.R."/>
<person name="Lian I."/>
<person name="Yu F.X."/>
<person name="Wang K."/>
<person name="Ho S.B."/>
<person name="Boland B.S."/>
<person name="Chang J.T."/>
<person name="Sandborn W.J."/>
<person name="Hardiman G."/>
<person name="Raz E."/>
<person name="Maehara Y."/>
<person name="Yoshimura A."/>
<person name="Zucman-Rossi J."/>
<person name="Guan K.L."/>
<person name="Karin M."/>
</authorList>
<dbReference type="PubMed" id="25731159"/>
<dbReference type="DOI" id="10.1038/nature14228"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2017" name="Mol. Cell. Biol." volume="37">
<title>SorLA in Interleukin-6 Signaling and Turnover.</title>
<authorList>
<person name="Larsen J.V."/>
<person name="Petersen C.M."/>
</authorList>
<dbReference type="PubMed" id="28265003"/>
<dbReference type="DOI" id="10.1128/mcb.00641-16"/>
</citation>
<scope>INTERACTION WITH IL6R AND SORL1</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2019" name="Immunity" volume="50" first="1007" last="1023">
<title>Targeting Interleukin-6 Signaling in Clinic.</title>
<authorList>
<person name="Kang S."/>
<person name="Tanaka T."/>
<person name="Narazaki M."/>
<person name="Kishimoto T."/>
</authorList>
<dbReference type="PubMed" id="30995492"/>
<dbReference type="DOI" id="10.1016/j.immuni.2019.03.026"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1996" name="Biochemistry" volume="35" first="273" last="281">
<title>Folding topologies of human interleukin-6 and its mutants as studied by NMR spectroscopy.</title>
<authorList>
<person name="Nishimura C."/>
<person name="Watanabe A."/>
<person name="Gouda H."/>
<person name="Shimada I."/>
<person name="Arata Y."/>
</authorList>
<dbReference type="PubMed" id="8555185"/>
<dbReference type="DOI" id="10.1021/bi951949e"/>
</citation>
<scope>STRUCTURE BY NMR</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1997" name="J. Mol. Biol." volume="268" first="468" last="481">
<title>Solution structure of recombinant human interleukin-6.</title>
<authorList>
<person name="Xu G.-Y."/>
<person name="Yu H.-A."/>
<person name="Hong J."/>
<person name="Stahl M."/>
<person name="McDonagh T."/>
<person name="Kay L.E."/>
<person name="Cumming D.A."/>
</authorList>
<dbReference type="PubMed" id="9159484"/>
<dbReference type="DOI" id="10.1006/jmbi.1997.0933"/>
</citation>
<scope>STRUCTURE BY NMR</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1997" name="EMBO J." volume="16" first="989" last="997">
<title>1.9-A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling.</title>
<authorList>
<person name="Somers W."/>
<person name="Stahl M."/>
<person name="Seehra J.S."/>
</authorList>
<dbReference type="PubMed" id="9118960"/>
<dbReference type="DOI" id="10.1093/emboj/16.5.989"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS)</scope>
</reference>
<reference key="31" evidence="2">
<citation type="journal article" date="2003" name="Science" volume="300" first="2101" last="2104">
<title>Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.</title>
<authorList>
<person name="Boulanger M.J."/>
<person name="Chow D.C."/>
<person name="Brevnova E.E."/>
<person name="Garcia K.C."/>
</authorList>
<dbReference type="PubMed" id="12829785"/>
<dbReference type="DOI" id="10.1126/science.1083901"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.65 ANGSTROMS) OF 29-212 IN COMPLEX WITH IL6ST AND IL6R</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="32">
<citation type="journal article" date="1998" name="J. Clin. Invest." volume="102" first="1369" last="1376">
<title>The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.</title>
<authorList>
<person name="Fishman D."/>
<person name="Faulds G."/>
<person name="Jeffery R."/>
<person name="Mohamed-Ali V."/>
<person name="Yudkin J.S."/>
<person name="Humphries S."/>
<person name="Woo P."/>
</authorList>
<dbReference type="PubMed" id="9769329"/>
<dbReference type="DOI" id="10.1172/jci2629"/>
</citation>
<scope>INVOLVEMENT IN RASJ</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2000" name="Blood" volume="96" first="2562" last="2567">
<title>An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus.</title>
<authorList>
<person name="Foster C.B."/>
<person name="Lehrnbecher T."/>
<person name="Samuels S."/>
<person name="Stein S."/>
<person name="Mol F."/>
<person name="Metcalf J.A."/>
<person name="Wyvill K."/>
<person name="Steinberg S.M."/>
<person name="Kovacs J."/>
<person name="Blauvelt A."/>
<person name="Yarchoan R."/>
<person name="Chanock S.J."/>
</authorList>
<dbReference type="PubMed" id="11001912"/>
</citation>
<scope>INVOLVEMENT IN SUSCEPTIBILITY TO KAPOSI SARCOMA</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2001" name="J. Hum. Genet." volume="46" first="267" last="272">
<title>A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density.</title>
<authorList>
<person name="Ota N."/>
<person name="Nakajima T."/>
<person name="Nakazawa I."/>
<person name="Suzuki T."/>
<person name="Hosoi T."/>
<person name="Orimo H."/>
<person name="Inoue S."/>
<person name="Shirai Y."/>
<person name="Emi M."/>
</authorList>
<dbReference type="PubMed" id="11355017"/>
<dbReference type="DOI" id="10.1007/s100380170077"/>
</citation>
<scope>INVOLVEMENT IN BMD</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2003" name="J. Hum. Genet." volume="48" first="243" last="248">
<title>Association of interleukin-6 promoter variant with bone mineral density in pre-menopausal women.</title>
<authorList>
<person name="Chung H.W."/>
<person name="Seo J.-S."/>
<person name="Hur S.E."/>
<person name="Kim H.L."/>
<person name="Kim J.Y."/>
<person name="Jung J.H."/>
<person name="Kim L.H."/>
<person name="Park B.L."/>
<person name="Shin H.D."/>
</authorList>
<dbReference type="PubMed" id="12768442"/>
<dbReference type="DOI" id="10.1007/s10038-003-0020-8"/>
</citation>
<scope>INVOLVEMENT IN BMD</scope>
</reference>
<comment type="function">
<text evidence="26">Cytokine with a wide variety of biological functions in immunity, tissue regeneration, and metabolism. Binds to IL6R, then the complex associates to the signaling subunit IL6ST/gp130 to trigger the intracellular IL6-signaling pathway (Probable). The interaction with the membrane-bound IL6R and IL6ST stimulates 'classic signaling', whereas the binding of IL6 and soluble IL6R to IL6ST stimulates 'trans-signaling'. Alternatively, 'cluster signaling' occurs when membrane-bound IL6:IL6R complexes on transmitter cells activate IL6ST receptors on neighboring receiver cells (Probable).</text>
</comment>
<comment type="function">
<text evidence="6 26">IL6 is a potent inducer of the acute phase response. Rapid production of IL6 contributes to host defense during infection and tissue injury, but excessive IL6 synthesis is involved in disease pathology. In the innate immune response, is synthesized by myeloid cells, such as macrophages and dendritic cells, upon recognition of pathogens through toll-like receptors (TLRs) at the site of infection or tissue injury (Probable). In the adaptive immune response, is required for the differentiation of B cells into immunoglobulin-secreting cells. Plays a major role in the differentiation of CD4(+) T cell subsets. Essential factor for the development of T follicular helper (Tfh) cells that are required for the induction of germinal-center formation. Required to drive naive CD4(+) T cells to the Th17 lineage. Also required for proliferation of myeloma cells and the survival of plasmablast cells (By similarity).</text>
</comment>
<comment type="function">
<text evidence="6 11 13 14 17 26">Acts as an essential factor in bone homeostasis and on vessels directly or indirectly by induction of VEGF, resulting in increased angiogenesis activity and vascular permeability (PubMed:17075861, PubMed:12794819). Induces, through 'trans-signaling' and synergistically with IL1B and TNF, the production of VEGF (PubMed:12794819). Involved in metabolic controls, is discharged into the bloodstream after muscle contraction increasing lipolysis and improving insulin resistance (PubMed:20823453). 'Trans-signaling' in central nervous system also regulates energy and glucose homeostasis (By similarity). Mediates, through GLP-1, crosstalk between insulin-sensitive tissues, intestinal L cells and pancreatic islets to adapt to changes in insulin demand (By similarity). Also acts as a myokine (Probable). Plays a protective role during liver injury, being required for maintenance of tissue regeneration (By similarity). Also has a pivotal role in iron metabolism by regulating HAMP/hepcidin expression upon inflammation or bacterial infection (PubMed:15124018). Through activation of IL6ST-YAP-NOTCH pathway, induces inflammation-induced epithelial regeneration (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="12 21">Component of a hexamer of two molecules each of IL6, IL6R and IL6ST; first binds to IL6R to associate with the signaling subunit IL6ST (PubMed:12829785). Interacts with IL6R (via the N-terminal ectodomain); this interaction may be affected by IL6R-binding with SORL1, hence decreasing IL6 cis signaling (PubMed:28265003). Interacts with SORL1 (via the N-terminal ectodomain); this interaction leads to IL6 internalization and lysosomal degradation (PubMed:28265003). May form a trimeric complex with the soluble SORL1 ectodomain and soluble IL6R receptor; this interaction might stabilize circulating IL6, hence promoting IL6 trans signaling (PubMed:28265003).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720533">
<id>P05231</id>
</interactant>
<interactant intactId="EBI-299383">
<id>P08887</id>
<label>IL6R</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720533">
<id>P05231</id>
</interactant>
<interactant intactId="EBI-1171329">
<id>Q92673</id>
<label>SORL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720533">
<id>P05231</id>
</interactant>
<interactant intactId="EBI-1057058">
<id>Q99523</id>
<label>SORT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720533">
<id>P05231</id>
</interactant>
<interactant intactId="EBI-711925">
<id>Q05516</id>
<label>ZBTB16</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8">Secreted</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="8">Produced by skeletal muscle.</text>
</comment>
<comment type="induction">
<text evidence="8">Plasma levels are highly increased upon exercise, due to enhanced production by contracting skeletal muscles.</text>
</comment>
<comment type="PTM">
<text evidence="15">N- and O-glycosylated.</text>
</comment>
<comment type="polymorphism">
<text evidence="9 10">Genetic variations in IL6 may be correlated with bone mineral density (BMD). Low BMD is a risk factor for osteoporotic fracture. Osteoporosis is characterized by reduced bone mineral density, disruption of bone microarchitecture, and the alteration of the amount and variety of non-collagenous proteins in bone. Osteoporotic bones are more at risk of fracture.</text>
</comment>
<comment type="disease" evidence="23">
<disease id="DI-02819">
<name>Rheumatoid arthritis systemic juvenile</name>
<acronym>RASJ</acronym>
<description>An inflammatory articular disorder with systemic onset beginning before the age of 16. It represents a subgroup of juvenile arthritis associated with severe extraarticular features and occasionally fatal complications. During active phases of the disorder, patients display a typical daily spiking fever, an evanescent macular rash, lymphadenopathy, hepatosplenomegaly, serositis, myalgia and arthritis.</description>
<dbReference type="MIM" id="604302"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="7">A IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in HIV-infected men.</text>
</comment>
<comment type="similarity">
<text evidence="25">Belongs to the IL-6 superfamily.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Interleukin_6"/>
<text>Interleukin-6 entry</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/il6/"/>
</comment>
<comment type="online information" name="SHMPD">
<link uri="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&amp;genename=IL6"/>
<text>The Singapore human mutation and polymorphism database</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/IL6ID519ch7p15.html"/>
</comment>
<dbReference type="EMBL" id="X04430">
<property type="protein sequence ID" value="CAA28026.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M14584">
<property type="protein sequence ID" value="AAA52728.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X04602">
<property type="protein sequence ID" value="CAA28268.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Y00081">
<property type="protein sequence ID" value="CAA68278.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M18403">
<property type="protein sequence ID" value="AAA52729.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M29150">
<property type="protein sequence ID" value="AAA59154.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X04402">
<property type="protein sequence ID" value="CAA27990.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X04403">
<property type="protein sequence ID" value="CAA27991.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M54894">
<property type="protein sequence ID" value="AAC41704.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S56892">
<property type="protein sequence ID" value="AAD13886.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF372214">
<property type="protein sequence ID" value="AAK48987.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC015511">
<property type="protein sequence ID" value="AAH15511.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5375.1"/>
<dbReference type="PIR" id="A32648">
<property type="entry name" value="IVHUB2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000591.1">
<property type="nucleotide sequence ID" value="NM_000600.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011513692.1">
<property type="nucleotide sequence ID" value="XM_011515390.2"/>
</dbReference>
<dbReference type="PDB" id="1ALU">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=28-212"/>
</dbReference>
<dbReference type="PDB" id="1IL6">
<property type="method" value="NMR"/>
<property type="chains" value="A=28-212"/>
</dbReference>
<dbReference type="PDB" id="1N2Q">
<property type="method" value="Model"/>
<property type="chains" value="E/F=30-212"/>
</dbReference>
<dbReference type="PDB" id="1P9M">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.65"/>
<property type="chains" value="B=29-212"/>
</dbReference>
<dbReference type="PDB" id="2IL6">
<property type="method" value="NMR"/>
<property type="chains" value="A=28-212"/>
</dbReference>
<dbReference type="PDB" id="4CNI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="C/D=42-212"/>
</dbReference>
<dbReference type="PDB" id="4J4L">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="C/D=47-212"/>
</dbReference>
<dbReference type="PDB" id="4NI7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=28-212"/>
</dbReference>
<dbReference type="PDB" id="4NI9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A/C=28-212"/>
</dbReference>
<dbReference type="PDB" id="4O9H">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.42"/>
<property type="chains" value="A=28-212"/>
</dbReference>
<dbReference type="PDB" id="4ZS7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.93"/>
<property type="chains" value="A=42-212"/>
</dbReference>
<dbReference type="PDB" id="5FUC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=49-212"/>
</dbReference>
<dbReference type="PDBsum" id="1ALU"/>
<dbReference type="PDBsum" id="1IL6"/>
<dbReference type="PDBsum" id="1N2Q"/>
<dbReference type="PDBsum" id="1P9M"/>
<dbReference type="PDBsum" id="2IL6"/>
<dbReference type="PDBsum" id="4CNI"/>
<dbReference type="PDBsum" id="4J4L"/>
<dbReference type="PDBsum" id="4NI7"/>
<dbReference type="PDBsum" id="4NI9"/>
<dbReference type="PDBsum" id="4O9H"/>
<dbReference type="PDBsum" id="4ZS7"/>
<dbReference type="PDBsum" id="5FUC"/>
<dbReference type="SMR" id="P05231"/>
<dbReference type="BioGRID" id="109783">
<property type="interactions" value="7"/>
</dbReference>
<dbReference type="DIP" id="DIP-482N"/>
<dbReference type="IntAct" id="P05231">
<property type="interactions" value="8"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000385675"/>
<dbReference type="BindingDB" id="P05231"/>
<dbReference type="ChEMBL" id="CHEMBL1795129"/>
<dbReference type="DrugBank" id="DB05767">
<property type="generic name" value="Andrographolide"/>
</dbReference>
<dbReference type="DrugBank" id="DB05513">
<property type="generic name" value="Atiprimod"/>
</dbReference>
<dbReference type="DrugBank" id="DB11967">
<property type="generic name" value="Binimetinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05744">
<property type="generic name" value="CRx-139"/>
</dbReference>
<dbReference type="DrugBank" id="DB12140">
<property type="generic name" value="Dilmapimod"/>
</dbReference>
<dbReference type="DrugBank" id="DB10770">
<property type="generic name" value="Foreskin fibroblast (neonatal)"/>
</dbReference>
<dbReference type="DrugBank" id="DB10772">
<property type="generic name" value="Foreskin keratinocyte (neonatal)"/>
</dbReference>
<dbReference type="DrugBank" id="DB01404">
<property type="generic name" value="Ginseng"/>
</dbReference>
<dbReference type="DrugBank" id="DB09221">
<property type="generic name" value="Polaprezinc"/>
</dbReference>
<dbReference type="DrugBank" id="DB09036">
<property type="generic name" value="Siltuximab"/>
</dbReference>
<dbReference type="DrugBank" id="DB06083">
<property type="generic name" value="Tapinarof"/>
</dbReference>
<dbReference type="DrugBank" id="DB05470">
<property type="generic name" value="VX-702"/>
</dbReference>
<dbReference type="DrugBank" id="DB05017">
<property type="generic name" value="YSIL6"/>
</dbReference>
<dbReference type="DrugCentral" id="P05231"/>
<dbReference type="GlyGen" id="P05231">
<property type="glycosylation" value="1 site"/>
</dbReference>
<dbReference type="iPTMnet" id="P05231"/>
<dbReference type="MetOSite" id="P05231"/>
<dbReference type="PhosphoSitePlus" id="P05231"/>
<dbReference type="BioMuta" id="IL6"/>
<dbReference type="DMDM" id="124347"/>
<dbReference type="MassIVE" id="P05231"/>
<dbReference type="PaxDb" id="P05231"/>
<dbReference type="PeptideAtlas" id="P05231"/>
<dbReference type="PRIDE" id="P05231"/>
<dbReference type="ProteomicsDB" id="51828"/>
<dbReference type="ABCD" id="P05231">
<property type="antibodies" value="186 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="12025">
<property type="antibodies" value="2741 antibodies"/>
</dbReference>
<dbReference type="CPTC" id="P05231">
<property type="antibodies" value="3 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="3569"/>
<dbReference type="Ensembl" id="ENST00000258743">
<property type="protein sequence ID" value="ENSP00000258743"/>
<property type="gene ID" value="ENSG00000136244"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000404625">
<property type="protein sequence ID" value="ENSP00000385675"/>
<property type="gene ID" value="ENSG00000136244"/>
</dbReference>
<dbReference type="GeneID" id="3569"/>
<dbReference type="KEGG" id="hsa:3569"/>
<dbReference type="CTD" id="3569"/>
<dbReference type="DisGeNET" id="3569"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000136244.11"/>
<dbReference type="GeneCards" id="IL6"/>
<dbReference type="HGNC" id="HGNC:6018">
<property type="gene designation" value="IL6"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000136244">
<property type="expression patterns" value="Tissue enhanced (adipose tissue, lymphoid tissue)"/>
</dbReference>
<dbReference type="MalaCards" id="IL6"/>
<dbReference type="MIM" id="147620">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="148000">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="604302">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P05231"/>
<dbReference type="OpenTargets" id="ENSG00000136244"/>
<dbReference type="Orphanet" id="206">
<property type="disease" value="NON RARE IN EUROPE: Crohn disease"/>
</dbReference>
<dbReference type="Orphanet" id="85414">
<property type="disease" value="Systemic-onset juvenile idiopathic arthritis"/>
</dbReference>
<dbReference type="PharmGKB" id="PA198"/>
<dbReference type="eggNOG" id="ENOG502S7Q4">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000000878"/>
<dbReference type="InParanoid" id="P05231"/>
<dbReference type="KO" id="K05405"/>
<dbReference type="OMA" id="YDKCENS"/>
<dbReference type="PhylomeDB" id="P05231"/>
<dbReference type="TreeFam" id="TF335984"/>
<dbReference type="PathwayCommons" id="P05231"/>
<dbReference type="Reactome" id="R-HSA-1059683">
<property type="pathway name" value="Interleukin-6 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-110056">
<property type="pathway name" value="MAPK3 (ERK1) activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-112411">
<property type="pathway name" value="MAPK1 (ERK2) activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559582">
<property type="pathway name" value="Senescence-Associated Secretory Phenotype (SASP)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381426">
<property type="pathway name" value="Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6783783">
<property type="pathway name" value="Interleukin-10 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and Interleukin-13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853884">
<property type="pathway name" value="Transcriptional Regulation by VENTX"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8957275">
<property type="pathway name" value="Post-translational protein phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9660821">
<property type="pathway name" value="ADORA2B mediated anti-inflammatory cytokines production"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9662834">
<property type="pathway name" value="CD163 mediating an anti-inflammatory response"/>
</dbReference>
<dbReference type="SignaLink" id="P05231"/>
<dbReference type="SIGNOR" id="P05231"/>
<dbReference type="BioGRID-ORCS" id="3569">
<property type="hits" value="4 hits in 872 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="IL6">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P05231"/>
<dbReference type="GeneWiki" id="Interleukin_6"/>
<dbReference type="GenomeRNAi" id="3569"/>
<dbReference type="Pharos" id="P05231">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P05231"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 7"/>
</dbReference>
<dbReference type="RNAct" id="P05231">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000136244">
<property type="expression patterns" value="Expressed in left coronary artery and 159 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P05231">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P05231">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005788">
<property type="term" value="C:endoplasmic reticulum lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005896">
<property type="term" value="C:interleukin-6 receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005125">
<property type="term" value="F:cytokine activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008083">
<property type="term" value="F:growth factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005138">
<property type="term" value="F:interleukin-6 receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006953">
<property type="term" value="P:acute-phase response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044267">
<property type="term" value="P:cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070301">
<property type="term" value="P:cellular response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071222">
<property type="term" value="P:cellular response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0098586">
<property type="term" value="P:cellular response to virus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050829">
<property type="term" value="P:defense response to Gram-negative bacterium"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050830">
<property type="term" value="P:defense response to Gram-positive bacterium"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031018">
<property type="term" value="P:endocrine pancreas development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002314">
<property type="term" value="P:germinal center B cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070091">
<property type="term" value="P:glucagon secretion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042593">
<property type="term" value="P:glucose homeostasis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002384">
<property type="term" value="P:hepatic immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0072574">
<property type="term" value="P:hepatocyte proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006959">
<property type="term" value="P:humoral immune response"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002377">
<property type="term" value="P:immunoglobulin production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032625">
<property type="term" value="P:interleukin-21 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070102">
<property type="term" value="P:interleukin-6-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097421">
<property type="term" value="P:liver regeneration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035633">
<property type="term" value="P:maintenance of blood-brain barrier"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002548">
<property type="term" value="P:monocyte chemotaxis"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045779">
<property type="term" value="P:negative regulation of bone resorption"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0045079">
<property type="term" value="P:negative regulation of chemokine biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032966">
<property type="term" value="P:negative regulation of collagen biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045599">
<property type="term" value="P:negative regulation of fat cell differentiation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000660">
<property type="term" value="P:negative regulation of interleukin-1-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010888">
<property type="term" value="P:negative regulation of lipid storage"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050768">
<property type="term" value="P:negative regulation of neurogenesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000635">
<property type="term" value="P:negative regulation of primary miRNA processing"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070050">
<property type="term" value="P:neuron cellular homeostasis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031175">
<property type="term" value="P:neuron projection development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001781">
<property type="term" value="P:neutrophil apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002446">
<property type="term" value="P:neutrophil mediated immunity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030168">
<property type="term" value="P:platelet activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002675">
<property type="term" value="P:positive regulation of acute inflammatory response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902512">
<property type="term" value="P:positive regulation of apoptotic DNA fragmentation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050871">
<property type="term" value="P:positive regulation of B cell activation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032722">
<property type="term" value="P:positive regulation of chemokine production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900017">
<property type="term" value="P:positive regulation of cytokine production involved in inflammatory response"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051091">
<property type="term" value="P:positive regulation of DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010718">
<property type="term" value="P:positive regulation of epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090091">
<property type="term" value="P:positive regulation of extracellular matrix disassembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060252">
<property type="term" value="P:positive regulation of glial cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051024">
<property type="term" value="P:positive regulation of immunoglobulin secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032731">
<property type="term" value="P:positive regulation of interleukin-1 beta production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032733">
<property type="term" value="P:positive regulation of interleukin-10 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032740">
<property type="term" value="P:positive regulation of interleukin-17 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032757">
<property type="term" value="P:positive regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904996">
<property type="term" value="P:positive regulation of leukocyte adhesion to vascular endothelial cell"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002690">
<property type="term" value="P:positive regulation of leukocyte chemotaxis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043410">
<property type="term" value="P:positive regulation of MAPK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0150078">
<property type="term" value="P:positive regulation of neuroinflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045669">
<property type="term" value="P:positive regulation of osteoblast differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033138">
<property type="term" value="P:positive regulation of peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0050731">
<property type="term" value="P:positive regulation of peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:1903800">
<property type="term" value="P:positive regulation of production of miRNAs involved in gene silencing by miRNA"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046427">
<property type="term" value="P:positive regulation of receptor signaling pathway via JAK-STAT"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904894">
<property type="term" value="P:positive regulation of receptor signaling pathway via STAT"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048661">
<property type="term" value="P:positive regulation of smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042102">
<property type="term" value="P:positive regulation of T cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000553">
<property type="term" value="P:positive regulation of T-helper 2 cell cytokine production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045727">
<property type="term" value="P:positive regulation of translation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042535">
<property type="term" value="P:positive regulation of tumor necrosis factor biosynthetic process"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904469">
<property type="term" value="P:positive regulation of tumor necrosis factor secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000676">
<property type="term" value="P:positive regulation of type B pancreatic cell apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042531">
<property type="term" value="P:positive regulation of tyrosine phosphorylation of STAT protein"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010575">
<property type="term" value="P:positive regulation of vascular endothelial growth factor production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043687">
<property type="term" value="P:post-translational protein modification"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045765">
<property type="term" value="P:regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0061888">
<property type="term" value="P:regulation of astrocyte activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070092">
<property type="term" value="P:regulation of glucagon secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050796">
<property type="term" value="P:regulation of insulin secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903978">
<property type="term" value="P:regulation of microglial cell activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0150077">
<property type="term" value="P:regulation of neuroinflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010574">
<property type="term" value="P:regulation of vascular endothelial growth factor production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0014823">
<property type="term" value="P:response to activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051384">
<property type="term" value="P:response to glucocorticoid"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032494">
<property type="term" value="P:response to peptidoglycan"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0061470">
<property type="term" value="P:T follicular helper cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072540">
<property type="term" value="P:T-helper 17 cell lineage commitment"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010573">
<property type="term" value="P:vascular endothelial growth factor production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR009079">
<property type="entry name" value="4_helix_cytokine-like_core"/>
</dbReference>
<dbReference type="InterPro" id="IPR003574">
<property type="entry name" value="IL-6"/>
</dbReference>
<dbReference type="InterPro" id="IPR030474">
<property type="entry name" value="IL-6/GCSF/MGF"/>
</dbReference>
<dbReference type="InterPro" id="IPR030473">
<property type="entry name" value="IL6/GCSF/MGF_CS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10511">
<property type="entry name" value="PTHR10511"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10511:SF3">
<property type="entry name" value="PTHR10511:SF3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00489">
<property type="entry name" value="IL6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF001935">
<property type="entry name" value="IL6_MGF_GCSF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00433">
<property type="entry name" value="IL6GCSFMGF"/>
</dbReference>
<dbReference type="SMART" id="SM00126">
<property type="entry name" value="IL6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47266">
<property type="entry name" value="SSF47266"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00254">
<property type="entry name" value="INTERLEUKIN_6"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0011">Acute phase</keyword>
<keyword id="KW-0202">Cytokine</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0339">Growth factor</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<feature type="signal peptide" evidence="15 20 22">
<location>
<begin position="1"/>
<end position="29"/>
</location>
</feature>
<feature type="chain" description="Interleukin-6" id="PRO_0000015582">
<location>
<begin position="30"/>
<end position="212"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by FAM20C" evidence="19">
<location>
<position position="81"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="15">
<location>
<position position="73"/>
</location>
</feature>
<feature type="disulfide bond" evidence="18">
<location>
<begin position="72"/>
<end position="78"/>
</location>
</feature>
<feature type="disulfide bond" evidence="18">
<location>
<begin position="101"/>
<end position="111"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2069830." id="VAR_013075" evidence="24">
<original>P</original>
<variation>S</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs13306435." id="VAR_029266">
<original>D</original>
<variation>E</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2069860." id="VAR_013076" evidence="24">
<original>D</original>
<variation>V</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="mutagenesis site" description="Almost no loss of activity." evidence="16">
<original>A</original>
<variation>V</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="mutagenesis site" description="No loss of activity." evidence="16">
<original>W</original>
<variation>R</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="mutagenesis site" description="87% loss of activity." evidence="16">
<original>S</original>
<variation>P</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity." evidence="16">
<original>R</original>
<variation>K</variation>
<variation>E</variation>
<variation>Q</variation>
<variation>T</variation>
<variation>A</variation>
<variation>P</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity." evidence="16">
<original>M</original>
<variation>T</variation>
<variation>N</variation>
<variation>S</variation>
<variation>R</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="49"/>
<end position="75"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="76"/>
<end position="79"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="81"/>
<end position="83"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="84"/>
<end position="87"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="97"/>
<end position="99"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="102"/>
<end position="105"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="108"/>
<end position="132"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="134"/>
<end position="136"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="137"/>
<end position="157"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="159"/>
<end position="161"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="169"/>
<end position="180"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="184"/>
<end position="209"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1ALU"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1P9M"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2IL6"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4CNI"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4J4L"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P08505"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11001912"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11080265"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11355017"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12768442"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12794819"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12829785"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15124018"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17075861"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1883960"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2037043"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20823453"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2472117"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26091039"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2610854"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28265003"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3279116"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9769329"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source ref="10"/>
</evidence>
<evidence key="25" type="ECO:0000305"/>
<evidence key="26" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="30995492"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:6018"/>
</source>
</evidence>
<sequence length="212" mass="23718" checksum="1F1ED1FE1B734079" modified="1987-08-13" version="1" precursor="true">MNSFSTSAFGPVAFSLGLLLVLPAAFPAPVPPGEDSKDVAAPHRQPLTSSERIDKQIRYILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

